U.S. Insurance Stock News

NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

Innoviva’s NUZOLVENCE Approval And Buyback Reframe Growth And Valuation Story

Innoviva (NasdaqGS:INVA) received FDA approval for NUZOLVENCE, a first in class treatment for uncomplicated urogenital gonorrhea. The company announced a US$125 million share repurchase program alongside the approval. These updates point to meaningful shifts in Innoviva's specialty therapeutics focus and capital allocation approach. For you as an investor, NUZOLVENCE adds a new approved therapy to Innoviva's portfolio, aligning with its push in specialty therapeutics. Gonorrhea treatment is...
NYSE:MA
NYSE:MADiversified Financial

Mastercard Leans Into Blockchain And Crypto While Shares Screen As Undervalued

Mastercard is expanding its blockchain efforts, including hiring a Director of Crypto Flows to lead stablecoin-linked cards and DeFi payment integration. The company is deepening partnerships with fintech players such as Ericsson and MetaMask to broaden its role in digital payments. Mastercard is working with Cloudflare to extend its cybersecurity offerings across payment and internet infrastructure. Mastercard (NYSE:MA), trading at $509.39, is leaning into crypto and blockchain...
NYSE:GAM
NYSE:GAMCapital Markets

How General American Investors’ 2025 Earnings Gap Between Revenue and Profit Could Reshape GAM’s Narrative

General American Investors Company, Inc. has reported its full-year 2025 results, posting revenue of US$24.31 million and net income of US$339.84 million for the year ended December 31, 2025. The contrast between relatively modest revenue and very large net income highlights how investment gains can significantly shape this closed-end fund’s financial profile. With this unusually wide gap between revenue and net income, we’ll explore what the latest earnings mean for General American...
NYSE:LXP
NYSE:LXPIndustrial REITs

What LXP Industrial Trust (LXP)'s 2025 Results and 2026 FFO Outlook Shift Means For Shareholders

LXP Industrial Trust has reported its fourth-quarter and full-year 2025 results, showing lower revenue but higher full-year net income, and confirmed it has repurchased 23,207,370 shares for US$223.45 million since its 2015 buyback authorization. Alongside earnings, the REIT issued 2026 guidance that pairs a wide net income range with much higher Adjusted Company FFO per share expectations, highlighting a growing gap between accounting profits and cash-flow-based performance metrics. We’ll...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Cipher Digital (CIFR) Q4 US$734 Million Loss Tests Bullish Profitability Narratives

Cipher Digital (CIFR) closed out FY 2025 with Q4 revenue of US$59.7 million and a basic EPS loss of US$1.85, alongside a net income loss of US$734.2 million. On a trailing 12 month basis, revenue was US$223.9 million and basic EPS stood at a loss of US$2.15. The company has seen quarterly revenue move from US$42.2 million in Q4 2024 to US$59.7 million in Q4 2025, while EPS shifted from US$0.05 to a loss of US$1.85 over the same period. This sets up a results season where investors will be...
NYSE:PFS
NYSE:PFSBanks

A Look At Provident Financial Services (PFS) Valuation After Recent Share Price Gains

Context for Provident Financial Services (PFS) Provident Financial Services (PFS) has attracted fresh attention after recent share price moves, with the stock roughly flat over the past day but showing mixed returns over the past week, month and past 3 months. See our latest analysis for Provident Financial Services. At a share price of US$21.91, Provident Financial Services has paired a softer 7 day share price return of 4.61% with a stronger 30 day gain of 6.41%. Its 1 year total...
NYSE:TE
NYSE:TEElectrical

T1 Energy (TE) Is Up 11.8% After CAO Shake-Up And Section 45X Tax Credit Backing

Earlier this week, T1 Energy replaced its chief accounting officer following an immediate termination and expressed support for U.S. Treasury guidance that confirms its eligibility for Section 45X tax credits tied to its domestic solar supply chain plans. The combination of leadership change and reinforced access to key tax incentives has sharpened investor focus on T1 Energy’s governance and policy-linked business model. Next, we’ll examine how the Treasury’s foreign entity of concern...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

Why Wynn Resorts (WYNN) Is Down 7.6% After Cyberattack Fallout And Profitability Pressures - And What's Next

In the fourth quarter of 2025, Wynn Resorts reported revenue of US$1,865.98 million and net income of US$100.03 million, while also declaring a US$0.25 per-share dividend and later confirming a cyberattack that exposed hundreds of thousands of employee records. The combination of weaker quarterly profitability, an ongoing data breach investigation, and a class-action lawsuit over alleged cybersecurity failures raises fresh questions about Wynn’s risk profile and operational resilience...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Tilray Carlsberg Deal Puts New Focus On U.S. Beer Growth

Tilray Brands has entered an exclusive multi year licensing deal with Carlsberg Group to produce, market, sell, and distribute Carlsberg, Carlsberg Elephant, and Kronenbourg 1664 beers in the U.S. The agreement covers all U.S. sales channels and is set to begin in January 2027. The move adds a new beer portfolio to Tilray's growing alcohol and lifestyle business. Ticker NasdaqGS:TLRY last closed at $7.83, with the share price showing a 3.3% gain over the past week but a 10.3% decline over...
NYSE:EME
NYSE:EMEConstruction

A Look At EMCOR Group (EME) Valuation After Strong Multi Year Shareholder Returns

Why EMCOR Group (EME) Is On Investors’ Radar Today EMCOR Group (EME) has attracted fresh attention after recent trading left the shares around $801.80, prompting investors to reassess the company’s fundamentals, recent returns, and valuation signals. See our latest analysis for EMCOR Group. While EMCOR Group’s share price eased slightly in the latest session, its 30-day share price return of 11.94% and year-to-date gain of 25.55% sit alongside a very large 5-year total shareholder return of...
NasdaqGM:MVIS
NasdaqGM:MVISElectronic

Should MicroVision’s New Secured Convertible Notes and Refinancing Strategy Require Action From MicroVision (MVIS) Investors?

In February 2026, MicroVision announced a series of senior secured zero-coupon convertible notes totaling US$43.0 million, including an exchange offer and new issuance of notes due March 1, 2028, alongside a business update and fireside chat on its lidar strategy. This refinancing shifts near-term repayment obligations and may give MicroVision more flexibility to pursue integration of recent lidar acquisitions and its broader technology roadmap. Next, we’ll examine how MicroVision’s new...
NasdaqGS:ADP
NasdaqGS:ADPProfessional Services

A Look At Automatic Data Processing’s Valuation After Solid Q2 2026 Results And NER Pulse Job Gains

Automatic Data Processing (ADP) drew fresh attention after reporting fiscal Q2 2026 results that management described as solid, alongside NER Pulse data showing four straight weeks of strengthening U.S. private job gains. See our latest analysis for Automatic Data Processing. The solid Q2 update and ongoing NER Pulse job gains arrived after a 17.0% 30 day share price decline and a 29.7% one year total shareholder return drop, leaving longer term total shareholder return over five years at...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

A Look At Intellia Therapeutics (NTLA) Valuation After Earnings Beat Trial Progress And FDA Hold Lift

Intellia Therapeutics (NTLA) is in focus after a busy stretch, with Q4 2025 results exceeding earnings and revenue expectations, encouraging hereditary angioedema trial data, and an FDA clinical hold lifted on its partnered gene editing drug. See our latest analysis for Intellia Therapeutics. At a share price of $13.42, Intellia has seen a 49.28% 90 day share price return and a 45.71% year to date share price return. However, the 3 year total shareholder return of a 69.49% decline shows that...
NYSE:MOH
NYSE:MOHHealthcare

A Look At Molina Healthcare (MOH) Valuation After Mixed Q4 Results Downgrades And Legal Scrutiny

Molina Healthcare (MOH) is back in focus after mixed fourth quarter results, earnings that missed expectations, multiple analyst downgrades, and a new shareholder law firm investigation into medical cost disclosures and growth assumptions. See our latest analysis for Molina Healthcare. That mixed fourth quarter and the string of downgrades have been reflected in the price, with a 30 day share price return of 27.6% decline and a year to date share price return of 18.4% decline. The 1 year...
NasdaqGS:ADEA
NasdaqGS:ADEASoftware

Why Adeia (ADEA) Is Up 11.5% After Record 2025 Results And Microsoft Licensing Deal – And What's Next

Adeia Inc. recently reported fourth-quarter 2025 revenue of US$182.64 million and net income of US$73.71 million, delivering record full-year results and issuing 2026 GAAP revenue guidance of US$395.0 million to US$435.0 million alongside a quarterly dividend of US$0.05 per share. These results were supported by 26 new license agreements, including multi-year deals with companies such as Microsoft and Disney, as Adeia continues shifting its revenue mix toward OTT and semiconductor markets...
NasdaqGS:CHTR
NasdaqGS:CHTRMedia

Charter Resets Growth Story With New COO WiFi 7 And Rural Push

Charter Communications (NasdaqGS:CHTR) named Nick Jeffery as Chief Operating Officer, adding senior telecom leadership experience aimed at operational change. The company introduced its Invincible WiFi product, described as the industry’s first WiFi 7 service with integrated battery and 5G backup. Charter outlined a rural network buildout focused on fiber expansion to underserved areas. The company launched a pledge that highlights up to $1,000 in savings for new broadband and mobile...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Advanced Energy Industries (AEIS) Is Up 5.3% After Q4 Beat And Insider Sale Filing Has The Bull Case Changed?

Earlier this week, Advanced Energy Industries reported fourth-quarter 2025 results that exceeded earnings and revenue expectations, while Executive Vice President and General Counsel Vonne Elizabeth Karpinski sold 964.001 shares of common stock on February 23, 2026 under a pre-arranged trading plan. The stronger-than-expected quarter, highlighted by robust performance in semiconductor-related demand, has sharpened investor focus on how Advanced Energy’s power solutions are positioned within...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Does Post‑Earnings Analyst Optimism Around clonoSEQ Adoption Change The Bull Case For Adaptive (ADPT)?

In recent days, Adaptive Biotechnologies received supportive research updates from TD Cowen, BTIG, and JPMorgan following the company’s strong Q4 results and improved outlook. Analysts emphasized growing community adoption of its clonoSEQ minimal residual disease testing and progress on new indications, underscoring Adaptive’s position within specialty laboratory diagnostics. Next, we’ll examine how this post‑earnings analyst optimism, particularly around clonoSEQ’s community adoption, may...
NYSE:TDY
NYSE:TDYElectronic

What Teledyne Technologies (TDY)'s Lepton XDS Dual-Spectrum Camera Launch Means For Shareholders

In February 2026, Teledyne FLIR OEM launched the Lepton XDS, an ITAR-free, dual-thermal-and-visible camera module that embeds its MSX edge-enhancement technology and Prism ISP software into a compact, low-power package for embedded, mobile, and industrial OEM applications. By combining radiometric thermal sensing, real-time thermal-visible fusion, and an industry-first RJPEG output in a SWaP-optimized module, Teledyne is pushing advanced imaging intelligence into space- and power-constrained...
NasdaqGM:PSNY
NasdaqGM:PSNYAuto

Polestar (PSNY) Is Up 20.4% After Unveiling Four-Model Expansion And Major Retail Buildout Plans

Earlier this month, Polestar announced its largest model expansion to date, planning four new vehicles by 2028, while targeting low double-digit volume growth in 2026 and a 30% expansion of its retail network. The company also highlighted meaningful progress on sustainability and technology, including emissions cuts per vehicle and the climate-focused Polestar 0 program, supported by a recent US$700,000,000 funding raise. We’ll now examine how this expanded four-model rollout and retail...
NYSE:PNC
NYSE:PNCBanks

Does PNC’s FirstBank Deal and Data‑Driven Expansion Strategy Reshape The Bull Case For PNC (PNC)?

Recently, PNC Financial Services Group announced the retirement of long-time executive Richard Bynum and promoted Stacy Juchno to chief corporate responsibility officer while elevating Mike Abriatis to general auditor and executive committee member, alongside unveiling new data products, community investments, lending deals and acquisition plans including an agreement to acquire FirstBank in Colorado and Arizona. Together with its new PNC Monthly Consumer Health Check and expanded affordable...
NYSE:PRU
NYSE:PRUInsurance

Is Prudential Financial (PRU) Pricing Look Attractive After Recent Share Price Weakness

If you are wondering whether Prudential Financial at around US$100.86 is offering fair value or a potential bargain, you are in the right place. The share price has seen a 3.3% decline over the last 7 days and a 7.5% decline over the last 30 days. The 3 year and 5 year returns of 17.3% and 43.5% give longer term holders a different picture compared with the 11.4% year to date and 5.1% 1 year declines. Recent coverage of Prudential Financial has focused on how investors interpret these mixed...
NYSE:ACM
NYSE:ACMConstruction

Is TomTom Traffic Data Access Quietly Redefining AECOM’s Digital Infrastructure Ambitions (ACM)?

Earlier in February, TomTom announced a global partnership with AECOM, giving AECOM access to TomTom’s real-time and historic traffic data products to enhance mobility planning, transport modelling, and traffic management for public and private clients worldwide. Alongside this partnership, AECOM’s upcoming presentations at Citi’s Global Industrial Tech & Mobility Conference and Barclays’ Industrial Select Conference highlight how data-driven, technology-enabled solutions are becoming more...
NYSE:BMY
NYSE:BMYPharmaceuticals

Is Bristol Myers Squibb (BMY) Pricing In Its 2024 Results And Product Pipeline Outlook?

If you are wondering whether Bristol-Myers Squibb is offering good value at today’s price, you are not alone. This article is built to help you frame that question clearly. The stock last closed at US$61.30, with returns of 2.6% over 7 days, 12.3% over 30 days, 14.7% year to date and 12.2% over 1 year, while the 3 year and 5 year figures are 1.3% and 23.1% respectively. Recent coverage has focused on Bristol-Myers Squibb’s position as a large established pharmaceutical group, with investors...